Monod Bio, a life sciences company using AI to generate new proteins for the research use only (RUO) and in vitro diagnostics (IVD) markets, announced today the launch of the LuxSit™ Pro family of products, the world’s smallest and first commercially-available de novo luciferases, which are light-emitting enzymes that use proprietary chemical substrates. The products are initially available in two formats: as a whole protein reporter, and as a split-pair for studying protein-protein interactions.
The LuxSit™ Pro family of products is biochemically optimized for stability and brightness. Overall performance has been improved more than 150-fold from its academic predecessor LuxSit.
